Anicom : Notice Regarding Application for Selection of New Market Segment “Prime Market”
November 24, 2021 at 03:20 am EST
Share
November 24, 2021
Company
Anicom Holdings, Inc.
Representative
Nobuaki Komori,
Representative Director
(Securities Code: 8715,
Tokyo Stock Exchange, First Section)
Inquiries to
Hiroshi Sato,
General Manager, Corporate Planning
Department
Notice Regarding Application for Selection of New Market Segment "Prime Market"
Anicom Holdings, Inc. (the "Company") received the results of its initial assessment from the Tokyo Stock Exchange, Inc. (the "TSE") on July 9, 2021 and confirmed that the Company complies with the listing criteria for the "Prime Market" in the new market segment.
Based on the results, the Board of Directors of the Company resolved at a Board of Directors meeting held on today to select and apply for the "Prime Market" in the transition to the new market segment of TSE scheduled to be implemented on April 4, 2022.
Hereafter, the Company will proceed with the prescribed procedures related to the application for the selection of the new market segment in accordance with the schedule set by the TSE.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Anicom Holdings Inc. published this content on 24 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 08:19:03 UTC.
Anicom Holdings Inc is a Japan-based company mainly engaged the non-life insurance business and other businesses. The Non-Life Insurance segment provides underwriting and asset management services for pet insurance. Pet insurance is a policy in which the contractor pays an insurance premium based on an insurance contract, and when the target pet receives medical treatment due to illness or injury during the insurance contract period, the insurance premiums are paid in accordance with the medical terms. Its sales channels are categorized into two channels including agency channels and direct sales channels. The Company is also involved in the animal hospital support business, insurance agency business, as well as the research and clinical business in the animal medicine field.